Gilead's lenacapavir reduced HIV infections by 96% in trial

A pharmacist holds a bottle of lenacapavir, the new injectable drug for HIV prevention. Nardus Engelbrecht | AP GileadPfizer's twice-yearly…

$1 billion in cost cuts and 10 planned product launches

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images…

Safi Biotherapeutics grows blood to help combat shortage

Safi employees at work. Courtesy of Safi Biotherapeutics Last month, the American Red Cross declared a blood shortage emergency after…